3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 33.95
+3.50 (11.49%)
Mar 24, 2026, 1:58 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.64 billion as of March 24, 2026. Its market cap has decreased by -42.46% in one year.
Market Cap
2.64B
Enterprise Value
1.96B
Revenue
324.87M
Ranking
n/a
PE Ratio
19.88
Stock Price
33.95
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 2.64B, a decrease of -3.42%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 2.64B | -29.71% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apex Biotechnology | 2.91B |
| Sunhawk Vision Biotech | 2.87B |
| HeXun Biosciences | 2.76B |
| GlycoNex Incorporation | 2.55B |
| Synbio Tech | 2.42B |
| Sinew Pharma | 2.40B |
| Sunny Pharmtech | 2.25B |
| Chunghwa Chemical Synthesis & Biotech | 2.23B |